Bank of Nova Scotia
BDSI

Bank of Nova Scotia’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bank of Nova Scotia’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13,926
Closed -$43K – 1355
2021
Q4 		$43K Buy
+13,926
New +$46.9K ﹤0.01% 1193

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.76B AUM 40.74% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Bank of Nova Scotia's BDSI Position: Q1 2022 in Review

Bank of Nova Scotia sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 13,926 shares — an estimated $43K sold.

Bank of Nova Scotia first reported a position in BDSI in Q4 2021 and held it in 1 quarter. The position peaked at $43K in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Bank of Nova Scotia reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Bank of Nova Scotia sold 13,926 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $43K.
  • Bank of Nova Scotia first reported a position in BioDelivery Sciences International, Inc. in Q4 2021 and held it in 1 quarter.
  • Bank of Nova Scotia's BioDelivery Sciences International, Inc. position peaked at $43K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Bank of Nova Scotia's 13F filing for Q1 2022, filed 9 May 2022.